Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Hansoh Pharma
Pharma
AZ-Summit, Novo-Hengrui, Merck—Fierce Pharma Asia
AstraZeneca invests in Summit, Novo bought a GLP-1/GIP drug from Hengrui, and Merck got a preclinical RAS(ON) inhibitor from China's SciBrunch.
Angus Liu
Oct 2, 2026 9:35am
Tagrisso rival loses EU approval after AZ legal challenge
Sep 30, 2026 11:13am
US' China deal policy, WCLC, Legend CEO—Fierce Pharma Asia
Sep 18, 2026 10:20am
Fierce Biotech
Hansoh heralds China’s move from ‘follower’ to ‘frontrunner’
Aug 26, 2026 9:33am
Legend Biotech, Merck, Otsuka—Fierce Pharma Asia
Jul 31, 2026 9:00am
GSK-Hansoh, Merck-Kelun, AZ-Dizal—Fierce Pharma Asia
Jul 17, 2026 9:38am
